SeraCare Launches New QC Software for Clinical Laboratories Running Next-Generation Sequencing Assays

MILFORD, Mass. — SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today that the company’s precision medicine business unit has launched a groundbreaking new laboratory QC software specifically for clinical laboratories running next-generation sequencing (NGS)-based assays. The iQ NGS QC Management Software is a cloud-based software tool, designed to help labs easily track, trend, and report all their labs’ NGS QC metrics for CAP CLIA audits.

Many clinical laboratories are rapidly adopting NGS-based methods due to the tremendous amounts of data they provide, as well as unique capabilities compared to previous methods such as detection of low allele frequency variants. This grants increased utility to direct treatment for the patient in applications such as oncology and infectious diseases. However, NGS workflows can be complex, with many different QC metrics that need to be tracked, organized, and easily accessed to ensure th

< | >